文献速递脑血管病外科神经重症

难治性脑血管痉挛连续介入动脉内治疗后的临床病程与监测参数

Clinical Course and Monitoring Parameters After Continuous Interventional Intra-Arterial Treatment in Patients with Refractory Cerebral Vasospasm.
PubMed 文献 · World Neurosurg · 2017-01-26

该回顾性观察分析纳入动脉瘤性蛛网膜下腔出血伴临床和/或影像学血管痉挛证据并接受动脉内介入治疗的患者97例、共163次干预,分为连续尼莫地平输注、重复尼莫地平输注和单次尼莫地平输注3组。连续治疗组世界神经外科医师联盟分级更高、对动脉内尼莫地平反应相对更差、术中并发症率显著更高,且3个月时无一例获得良好结局。作者结论为对血管造影难治性脑血管痉挛的连续动脉内尼莫地平输注须严格掌握指征。

要点

  • 连续尼莫地平输注组患者的世界神经外科医师联盟分级更高。
  • 连续组对动脉内尼莫地平的反应相对更差,术中并发症率显著更高。
  • 连续组3个月时无一例获得良好结局,经颅多普勒和脑组织氧合监测与影像结果相关性良好。

核心结论

  • 面对较差的临床结局和更高的并发症率,对血管造影难治性脑血管痉挛患者行连续动脉内尼莫地平输注须严格掌握指征。
  • 经颅多普勒和脑组织氧合监测似乎是评估介入后临床病程的可靠工具。

研究设计与样本

  • 回顾性观察分析,纳入动脉瘤性蛛网膜下腔出血伴临床和/或影像学血管痉挛证据并接受动脉内介入治疗的患者。
  • 共检查163次干预(97例患者),分为连续尼莫地平输注、重复尼莫地平输注和单次尼莫地平输注3组。
  • 分析干预前后参数以评估操作疗效(以应答者状态判定),结局采用改良Rankin量表确定。

主要发现

  • 连续治疗组患者的世界神经外科医师联盟分级更高。
  • 连续组对动脉内尼莫地平的反应相对更差。
  • 经颅多普勒监测及脑组织氧合测量与影像结果相关性良好。
  • 连续治疗组术中并发症率显著更高。
  • 连续治疗组患者临床结局更差,且该组3个月时无一例患者获得良好结局。

临床怎么用

  • 作者认为,对血管造影难治性脑血管痉挛患者行连续动脉内尼莫地平输注须严格掌握指征。
  • 作者认为,经颅多普勒和脑组织氧合监测似乎是评估介入后临床病程的可靠工具。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In aneurysmal subarachnoid haemorrhage cerebral vasospasm leads to clinical worsening and poor outcome. Interventional treatment with nimodipine might be a therapeutic option. OBJECTIVE: To evaluate the clinical course of patients with different interventional treatment types. METHODS: A retrospective, observational analysis was performed. Inclusion criteria were aneurysmal subarachnoid haemorrhage, clinical and/or radiologic evidence of vasospasm and interventional intra-arterial treatment. Patients were divided into 3 groups: continuous nimodipine infusion, repetitive nimodipine infusions, and singular nimodipine infusion. Pre- and postinterventional parameters were analyzed to evaluate the efficacy of the procedure in terms of responder status. Outcome was determined using the modified Rankin scale. RESULTS: A total of 163 interventions (97 patients) were examined. Patients with continuous treatment showed a greater World Federation of Neurological Surgeons grade. Response to intra-arterial nimodipine in the continuous group was comparatively worse. Transcranial Doppler monitoring as well as brain tissue oxygenation measuring showed good correlation with imaging results. The rate of intraprocedural complications in the continuous treatment group was significantly greater. We observed a worse clinical outcome in the patients who underwent continuous treatment. None of the patients in the continuous group achieved favorable outcome after 3 months. CONCLUSIONS: Facing the poor clinical outcome and the greater complication rate, continuous intra-arterial infusion of nimodipine in patients with angiographically refractory cerebral vasospasm has to be indicated strictly. Transcranial Doppler and brain tissue oxygenation monitoring seem to be reliable tools for evaluation of the clinical postinterventional course.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. von der Brelie C, Doukas A, Stopfer A, et al. Clinical Course and Monitoring Parameters After Continuous Interventional Intra-Arterial Treatment in Patients with Refractory Cerebral Vasospasm. World Neurosurg. 2017. PMID: 28131927. doi:10.1016/j.wneu.2016.12.110

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。